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Abstract: Essential oils (EOs) from Salvia dolomitica and Salvia somalensis, widely employed in the
cosmetic and perfume industry, were analyzed for composition and tested against bacterial and
fungal pathogens isolated from clinical and environmental specimens. The analyses were carried out
against Staphylococcus aureus, Staphylococcus pseudointermedius, Pseudomonas aeruginosa, Escherichia coli,
Streptococcus canis, Streptococcus pyogenes, Klebsiella pneumoniae, Proteus mirabilis, Microsporum canis,
Microsporum gypseum, Trichophyton mentagrophytes, Aspergillus niger, Aspergillus flavus, Candida albicans,
Candida krusei, Mucor sp. and Trichothecium roseum. Both EOs showed similar percentages of
total monoterpenes and sesquiterpene hydrocarbons. The main constituents were 1,8-cineole and
β-caryophyllene in S. dolomitica and bornyl acetate and camphor in S. somalensis. The selected EOs
have no relevant antifungal or antibacterial activities if compared to conventional drugs.
Keywords: Salvia dolomitica; Salvia somalensis; antibacterial activity; antifungal activity
1. Introduction
The genus Salvia belongs to the family Lamiaceae and includes about 900 species spread
throughout the world. Taxa of Salvia spp. (sage) are mainly aromatic plants, rich in essential oils
(EOs) and widely employed in foods, perfumery and cosmetics [1]. EOs from Salvia spp. are rich in
monoterpene hydrocarbons (MH), oxygenated monoterpenes (OM) and sesquiterpenes [2].
Natural products isolated from Salvia spp. have long been used in traditional medicine to
treat several microbial afflictions [2], but considering the high number of species of this genus, the
antimicrobial properties of all of them is not well known. Salvia dolomitica Codd and Salvia somalensis
Vatke are two species native to Africa. The first sage is an aromatic perennial shrub able to grow
on heavy soils with dolomitic rocks. EO from S. dolomitica has been suggested as an antiplasmodial
and antiinflammatory remedy. Its antimicrobial activity against some bacteria has been described [3].
S. somalensis is a wild sage native to Somalia. A potential cosmetic application of its EO has been
proposed for its peculiar olfactive characters [4], but data about its antimicrobial activity are not
available in the scientific literature. Considering that EOs from these botanical species are already
employed, the aim of the present investigation was to verify the activity of EOs from S. dolomitica and
S. somalensis against bacterial and fungal pathogens previously isolated from clinical and environmental
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specimens. These organisms were selected for their relevance in veterinary practice and/or in
foodstuff preservation.
2. Results
2.1. EO Analysis
The EOs’ composition is reported in Table 1. A total of 59 compounds were characterized,
with identification percentages ranging from 98.5% in S. somalensis to 98.9% in S. dolomitica.
The monoterpenes class was the most abundant in both samples (73.1% in S. dolomitica and 67.8%
in S. somalensis). 1,8-Cineole was the main constituent in S. dolomitica (18.9%), while bornyl acetate
(16.1%) together with camphor (12.5%), showed the highest percentage in S. somalensis. Among the
sesquiterpenes, sesquiterpene hydrocarbons (SH) exhibited a higher relative amount in comparison
with the oxygenated sesquiterpenes (OS) in both samples. β-Caryophyllene predominated in
S. dolomitica (13.1%) and δ-cadinene in the other sage sample (6.4%).
Table 1. EO analysis of Salvia dolomitica and Salvia somalensis aerial parts.
No. Class Component L.R.I. §
Relative Content (%)
S. dolomitica S. somalensis
1 MH α-Thujene 930 0.25 tr
2 MH Tricyclene 932 0.10 tr
3 MH α-Pinene 939 9.60 9.28
4 MH Camphene 955 5.23 8.04
5 MH Sabinene 978 0.77
6 MH β-Pinene 981 1.31
7 MH Myrcene 993 2.73 1.23
8 MH δ-2-Carene 1002 6.68 6.29
9 MH α-Phellandrene 1006 0.82 0.47
10 MH α-Terpinene 1019 0.95 0.48
11 MH p-Cymene 1025 1.55 1.55
12 MH Limonene 1032 8.94 4.62
13 OM 1,8-Cineole 1036 18.91 tr
14 MH ( Z)-β-Ocimene 1037 2.66 tr
15 MH ( E)-β-Ocimene 1053 0.39 tr
16 MH γ-Terpinene 1058 1.13 0.47
17 MH para-Mentha-2,4(8)-diene 1088 0.39 0.14
18 MH Terpinolene 1090 0.21 0.74
19 OM Linalool 1102 0.17 0.23
20 OM trans-Thujone 1117 0.10
21 OM Camphor 1148 12.52
22 OM Borneol 1169 6.57 2.79
23 OM 4-Terpineol 1180 0.59 0.67
24 OM α-Terpineol 1192 0.11 1.26
25 NT ( Z)-Butanoic acid 1236 0.12
26 OM Bornyl acetate 1289 16.15
27 SH α-Cubebene 1351 0.20 0.31
28 SH Cyclosativene 1371 0.68
29 SH Isoledene 1376 0.31
30 SH α-Copaene 1377 1.69 3.46
31 OM ( Z)-Jasmone 1397 0.10
32 SH Cyperene 1399 0.55
33 SH α-Gurjunene 1410 0.89
34 SH β-Caryophyllene 1418 13.12 4.52
35 SH β-Gurjunene 1434 0.62 0.19
36 SH α-Guaiene 1440 0.46 1.37
37 SH cis-Muurola-3,5-diene 1450 0.11
38 OM trans-Carvyl propanoate 1455 3.68
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Table 1. Cont.
No. Class Component L.R.I. §
Relative Content (%)
S. dolomitica S. somalensis
39 SH α-Humulene 1456 1.08 0.35
40 SH allo-Aromadendrne 1460 0.31 0.43
41 SH trans-Cadina-1(6),4-diene 1477 0.35 0.59
42 SH γ-Muurolene 1480 0.37 0.78
43 SH γ-Curcumene 1481 0.24
44 SH Germacrene D 1484 0.5
45 SH β-Selinene 1490 0.21 0.1
46 SH cis-β-Guaiene 1493 0.13 0.17
47 SH Valencene 1496 1.43 0.73
48 SH Viridiflorene 1497 0.51
49 SH trans-β-Guaiene 1503 0.88
50 SH trans-γ-Cadinene 1513 1.35 3.11
51 SH δ-Cadinene 1523 2.54 6.43
52 SH trans-Cadina-1(2),4-diene 1535 0.24 0.56
53 SH α-Cadinene 1539 0.10 0.25
54 SH α-Calacorene 1546 tr 0.37
55 OS trans-Nerolidol 1566 0.64
56 OS Caryophyllene oxide 1583 0.14
57 OS 1- epi-Cubenol 1630 tr 0.66
58 OS Hinesol 1638 0.14 1.99
59 OS Cubenol 1641 0.21
Non terpenic compounds (NT) 0.12 0.00
Monoterpene hydrocarbons (MH) 42.94 34.08
Oxygenated monoterpenes (OM) 30.13 33.72
Total monoterpenes (TM) 73.07 67.80
Sesquiterpene hydrocarbons (SH) 25.57 27.02
Oxygenated sesquiterpenes (OS) 0.14 3.64
Total sesquiterpenes (TS) 25.71 30.66
Total identified 98.90 98.46
§: Linear retention index.
2.2. Antibacterial Activity
2.2.1. Agar Disk Diffusion Method
The agar disk diffusion method showed that EO from S. somalensis did not inhibit any tested
bacterial isolate; conversely S. dolomitica EO had a low effectiveness at 10% dilution (MIC 16.26 mg/mL)
against Streptococcus canis, Klebsiella pneumoniae and Proteus mirabilis. No inhibition zone was observed
for the negative control. Results of the Kirby-Bauer assay are reported in Table 2.
Table 2. Results (inhibition zone expressed in mm) of the Kirby-Bauer assay testing the selected
bacterial strains against four antibiotics.
Antibiotics (30 µg)
Bacterial Strains Amikacin Amoxycillin + Clavulanic Acid Cefotaxime Tetracycline
Staphylococcus aureus 18 (S) 20 (S) 16 (I) 12 (R)
Staphylococcus pseudointermedius 19 (S) 21 (S) 23 (S) 11 (R)
Streptococcus canis 19 (S) 21 (S) 23 (S) 20 (S)
Streptococcus pyogenes 20 (S) 23 (S) 23 (S) 20 (S)
Pseudomonas aeruginosa 12 (R) 20 (S) 17 (I) 12 (R)
Escherichia coli 13 (R) 22 (S) 25 (S) 21 (S)
Proteus mirabilis 20 (S) 22 (S) 24 (S) 20 (S)
Klebsiella pneumoniae 15 (I) 20 (S) 24 (S) 10 (R)
Legend—S: susceptible; R: resistant; I: intermediate. Breakpoint values: amikacin ≤ 14 mm R, 15–16 mm I,
≥17 mm S; amoxicillin + clavulanic acid ≤ 19 mm R (staphylococci), ≤13 mm R (remaining bacteria), 14–17 mm
I, ≥20 mm (staphylococci) S, ≥18 mm (remaining bacteria) S; cefotaxime ≤ 14 mm R, 15–22 mm I, ≥23 mm S;
tetracycline ≤ 14 mm R, 15–18 mm I, ≥19 mm S.
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2.2.2. Minimum Inhibitory Concentration
Similar results were obtained by the broth microdilution method. In fact, MIC values of
16.26 mg/mL were observed when S. dolomitica EO was tested against S. canis, K. pneumoniae and
P. mirabilis, whereas bacterial growth was found for the remaining isolates. All bacterial strains were
not inhibited by S. somalensis EO. Bacterial growth was observed when bacteria had been incubated
with brain hearth infusion broth (BHIB, Oxoid Ltd., Basingstoke, Hampshire, UK) without EOs,
whereas it was not detected in the sterility control wells.
2.3. Antifungal Activity
The examined EOs showed variable degrees of antimycotic activity towards tested fungal isolates.
From a general point of view, molds appeared more prone to the selected EOs rather than yeasts.
Microsporum gypseum appeared to be the most sensitive fungal species, inhibited by 1.70 mg/mL
of S. somalensis EO with IC50 0.84. Moreover, Mucor sp. and Trichothecium roseum did not show a
visible growth at 4.06 mg/mL (IC50 2.07) of S. dolomitica, and 5.11 mg/mL (IC50 4.42) of S. somalensis,
respectively. Candida spp. and Aspergillus spp. employed were susceptible to selected conventional
drugs. Mycotic growth was observed in negative control wells (without EOs). All the results of EOs
and results of conventional drugs, with available clinical breakpoints are reported in Table 3.
Table 3. Results of microdilution assay testing S. somalensis and S. dolomitica EOs and conventional
antimycotic drugs against fungal strains from different sources.
Essential Oils
Fungal Strains Source of
Isolates
S. somalensis S. dolomitica
Conventional
Drugs (mg/mL)
CLSI
Clinical
Breakpoint
MIC
(mg/mL)
IC50
(mg/mL)
MIC
(mg/mL)
IC50
(mg/mL)
Microsporum canis feline hair 17.04 12.8 16.26 11.62 ITZ (0.125) -
Microsporum gypseum feline hair 1.70 0.84 4.88 4.26 ITZ (32) -
Trichophyton mentagrophytes canine hair 17.04 12.8 16.26 11.62 ITZ (32) -
Aspergillus niger environment 8.52 7.84 8.13 4.48 AmB (1.5) 2
Aspergillus flavus environment 17.04 12.8 16.26 11.62 AmB (1) 2
Candida albicans canine feces 17.04 12.8 16.26 11.62 FLU (0.25 × 10−3) 8
Candida krusei canine feces 17.04 12.8 16.26 11.62 AmB (0.5) 1
Mucor sp. environment 8.52 7.84 4.06 2.07 AmB (0.5) -
Trichothecium roseum environment 5.11 4.42 8.13 4.48 Thiabendazole (4) -
Legend—ITZ: itraconazole; FLU: Fluconazole; AmB: Amphotericine B; CSP: Caspofungin.
3. Discussion
S. dolomitica Codd is an aromatic perennial shrub, native of the North-East province of Transvaal in
Southern Africa. The species name refers to its frequent occurrence on soil with dolomite rock. This sage
is highly scented and drought resistant [5]. S. dolomitica is mainly commercialized for ornamental
purposes and can be cultivated in pots and used as groundcover, shrub border or edging [6].
Fisher [7] and Kamatou et al. [8] characterized EOs from fresh aerial parts of S. dolomitica Codd
grown in open fields in South Africa. The comparison between the analysis of the EO obtained from
S. dolomitica grown in the Cape region of South Africa and our plant collected in Sanremo (Italy)
showed a different behaviour, since the South African sample had a high percentage of geraniol (19.6%)
and linalyl acetate (19.6%), totally absent in our sample, followed by linalool and α-terpineol (16.6%
and 6.2%, respectively) [8]. The composition of our S. dolomitica EO also differed from the other South
African sample [7] for the amounts of main constituents. In detail South African sample was composed
of 17.6% of β-caryophyllene, 17.4% of 1,8-cineole, 9.7% of limonene, 8.5% of borneol, 7.5% of δ-3 carene
and 7.1% of α-pinene. S. dolomitica EO of the present study showed almost the same compounds in
different amounts: 18.9% of 1,8-cineole, 13.2% of β-caryophyllene, 9.6% of α-pinene, 8.9% of limonene,
6.7% of δ-2 carene, 6.6% of borneol and 5.2% camphene.
S. somalensis Vatke EO, recovered after hydrodistillation of the dried aerial parts, has its main
practical application in the cosmetic industry. This taxon is a wild plant native to Somalia, where it
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grows in full sun to partial shade. S. somalensis is characterized by a pleasant fragrance and it is well
known as easy-to-grow ornamental plant especially in dry gardens, due to its drought tolerance [4]. The
EO obtained from S. somalensis showed a chemical profile very similar to that reported by Villa et al. [4].
However δ-cadinene and α-copaene had higher percentages in our sample (6.43% versus 0.26% and
3.46% versus 1.43%, respectively).
To the best of our knowledge no studies about the antimicrobial activity of S. somalensis are
reported in the scientific literature. In the present paper, S. somalensis was ineffective against all the
tested bacterial strains, while S. dolomitica had a very low activity against S. canis, K. pneumoniae and
P. mirabilis.
The EOs examined in the present study are characterized by different composition, apart from
their content in α-pinene. Bornyl acetate and camphor were the main constituents in S. somalensis,
compounds totally absent in S. dolomitica EO, where 1,8-cineole and β-caryophyllene showed the
highest percentages. These pure compounds are known to be active as antimicrobial agents [9,10].
Little information is available about the antimicrobial activity of S. dolomitica. Fisher [7] reported
a slight activity of S. dolomitica EO against Bacillus cereus, but not against Escherichia coli, S. aureus,
K. pneumoniae and Yersinia enterocolitica.
Previous investigations on other Salvia spp. reported antimicrobial activity of Salvia sclarea EO
against P. aeruginosa and mainly S. pseudointermedius [11], whereas S. dolomitica and S. somalensis EOs
tested herein had no inhibition activity against these bacterial strains.
On the basis of the results obtained in previous studies, Gram positive bacteria would seem to
be more sensitive to Salvia spp. EOs than Gram negative bacteria [12,13]. The present investigation
does not confirm this hypothesis, because inhibition activity of S. dolomitica was observed against both
Gram positive (S. canis) and Gram negative (K. pneumoniae and P. mirabilis) bacteria.
All the tested bacteria used in this work were clinical isolates. In fact, these species can be
frequently found in cases of septicemia and infections of ears, skin, genitourinary and gastrointestinal
tracts. Treatment with antibiotics is usually performed, even though the infection’s resolution is not
obtained in some cases because of the antibiotic-resistance of the etiologic agents.
To the best of our knowledge this is the first study dealing with the antimycotic activity of these
Salvia species. The antifungal action of the EOs yielded some interesting findings. S. dolomitica and
S. somalensis EOs appeared active against Mucor sp. and T. roseum, respectively. These fungi are spoiling
molds of foodstuff, so a possible use of the investigated EOs as food additives could be suggested.
Small amounts of both EOs appeared to be active against M. gypseum, a dermatophyte responsible for
ringworm both in animals and in humans. Furthermore, this mold is reported to possess a limited
sensitivity versus conventional antimycotic drugs such as griseofulvin [14] and itraconazole [15].
For this reason these compounds could be evaluated as active ingredients of shampooing/lotion
formulations intended for local application. The major components of both examined EOs such as
1,8 cineole, bornyl acetate, β-caryophyllene, α-pinene, camphor were shown to possess antifungal
activity [16], in particular EOs containing such components were effective against Fusarium spp. [17],
Heterobasidion parviporum [18] and EOs from plants rich in bornyl acetate and α-pinene showed
antimycotic action [19,20].
β-Caryophyllene is reported to have a fungicide activity versus Aspergillus niger and
Aspergillus fumigatus [21], while 1,8 cineole has showed high MICs against Microsporum canis and
M. gypseum [15]. The EOs used in the present study did not give good results when assayed against
aspergilli, in contrast with a previous report referred to S. sclarea, while the lack of activity against
Candida yeasts was confirmed [11]. However, data from the literature showed that S. officinalis was
active against yeasts, aspergilli and dermatophytes [22], while Salvia fruticosa was highly effective
versus dermatophytes [23] and phytopathogenic fungi [24].
Some papers are referred to EOs from plants in which such active principles were present in
higher amounts [17]. Being represented in amounts lower than 20%, they could be responsible for
their moderate antifungal effect.
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Sage EOs have been proposed for antimicrobial treatments [3]. However, several species of the
genus Salvia occur worldwide and their different chemical compositions have been demonstrated
in several studies [25]. These differences could be due to several factors, including their habitat,
cultivation methods and extraction procedures. Thus the antimicrobial activity of different botanical
species should be thoroughly verified, according to their chemotype.
4. Material and Methods
4.1. Essential Oils
S. dolomitica Codd (Voucher number PI010354) and S. somalensis Vatke (Voucher number PI010355)
belong to a collection coming from the CREA (Centro di ricerca Orticoltura e Florovivaismo) located
in Sanremo (Liguria, Italy) and collected in 2015. Both the Salvia spp. were vegetatively propagated,
planted and grown under uniform conditions. The aerial parts were dried and hydrodistillated for 2 h
to obtain the respective EOs, that were maintained at 4 ◦C in dark glass vials and microbiologically
tested for quality control before use.
4.2. Gas Chromatography-Mass Spectrometry Analysis
The GC-MS analysis and the identification of the constituents in both EOs were performed
following a previously reported protocol [26].
4.3. Antibacterial Activity
4.3.1. Bacterial Strains
Both EOs were tested against the following bacterial species: S. aureus, S. pseudointermedius,
P. aeruginosa, E. coli, S. canis, S. pyogenes, K. pneumoniae, P. mirabilis. All the strains have been previously
isolated from clinical specimens collected from dogs with different pathologies, such as infection of
ear, skin and genitourinary tract.
4.3.2. Agar Disk Diffusion Method
The antibacterial activity of both EOs was determined with the Agar disk diffusion method
following the procedures described by Clinical and Laboratory Standards Institute (CLSI) [27] and
with some modifications as previously described [28]. Each EO was tested at a 1:10 dilution in dimethyl
sulfoxide (DMSO, Oxoid Ltd.). An absorbent paper disc impregnated with 10 µL of DMSO was used
as negative control. Paper discs impregnated with amikacin (30 µg), amoxycillin-clavulanic acid
(30 µg), cefotaxime (30 µg), tetracycline (30 µg) (Oxoid Ltd.), respectively, were used as positive
controls. The results of the bacterial in vitro sensitivity to antibiotics were interpreted as indicated by
the CLSI [29]. All tests were performed in triplicate.
4.3.3. Minimum Inhibitory Concentration
Each bacterial strain was also submitted to MIC determination. MIC was evaluated by the broth
microdilution method following the protocol previously reported [28]. The test was performed in a
total volume of 200 µL with final EOs concentrations of 16.26 to 2.03 mg/mL for S. dolomitica, 17.04 to
2.13 mg/mL for S. somalensis. The same assay, carried out in BHIB was simultaneously performed for
bacterial growth control (tested bacteria and BHIB) and sterility control (tested oil and BHIB). All tests
were performed in triplicate.
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4.4. Antifungal Activity
4.4.1. Fungal Strains
Isolates of dermatophytes (M. canis, M. gypseum, Trichophyton mentagrophytes) and yeasts
(Candida albicans and Candida krusei) were obtained from animal specimens. Other molds such as
A. niger, Aspergillus flavus, Mucor sp. and T. roseum were isolated from environmental sources and were
used for in vitro sensitivity assays. These fungi were selected for their impact on both animal and
human health. In particular dermatophytes are keratinophilic and keratinolytic molds able to infect
both animal and human teguments and annexes, responsible for ringworm. C. albicans and C. krusei
are endo- and esosaprophytic yeasts, respectively, known as causative agents of superficial mycoses
(stomatitis, vulvovaginitis) in immunocompetent hosts, and deep generalized life threatening infections
in immunocompromised patients. A. niger, A. flavus, Mucor sp. and T. roseum are environmental
food-spoiling molds. Furthermore A. flavus, and T. roseum are toxigenic fungi, able to elaborate
secondary metabolites, such as aflatoxins and trichothecenes on foodstuff, which can cause severe
chronic lesions in consumers. All molds (dermatophytes and environmental fungi) were maintained
on Potato Dextrose Agar at −20 ◦C, while yeasts were stored into sterile distilled water.
4.4.2. Microdilution Test
The antimycotic activity of EOs was essayed by a microdilution test carried out as recommended
by Clinical and Laboratory Standards Institute M38A2 [30] for molds and Clinical and Laboratory
Standards Institute M27A3 [31] for yeasts, starting from a 10% dilution corresponding to 17.04 mg/mL
(S. somalensis) and 16.26 mg/mL (S. dolomitica), respectively, and 7.5%, 5%, 3%, 2% and 1% further
dilutions were achieved. All assays were performed in triplicate. Controls were also achieved using
conventional antifungal drugs. Clinical breakpoint of standard drugs referred to Aspergillus and
Candida species provided by CLSI were taken into consideration.
5. Conclusions
Our results show that S. somalensis and S. dolomitica EOs, largely employed in cosmetic and
perfume industry, have not relevant both antifungal and antibacterial activities if compared to
conventional drugs. So these EOs cannot be considered promising candidates not even against
fungal organisms with lower sensitivity such as M. gypseum, Mucor sp. and T. roseum.
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